REPROCELL USA Secures Funding from Maryland Stem Cell Research Fund (MSCRF)
REPROCELL USA, a leader in the production of clinically relevant human induced pluripotent stem cells (hiPSCs), has announced the receipt of funding from the Maryland Stem Cell Research Fund (MSCRF) for both of its proposals submitted in the January 2024 grant cycle. These grants will significantly enhance the company’s capabilities in cell therapy and therapeutic […]
Induced Pluripotent Stem Cells (iPSCs): Creation and Applications
Welcome, dear readers! Today, we’re embarking on a journey into the microscopic world of cells, specifically stem cells. These aren’t just any ordinary cells; they’re like the superheroes of the cellular world. Imagine a cell that can morph into any cell type in the body, much like a superhero changing disguises. That’s the power of […]
Trailblazing Stem Cell Research: New Hope for Schizophrenia Patients
A recent study led by Dr. Sergiu Pasca at Stanford University suggests that human induced pluripotent stem cells (iPSCs) could be used to identify potential new medications for schizophrenia. The research team developed a novel technique to produce astrocytes, star-shaped cells that support neurons, from iPSCs derived from patients with schizophrenia. Astrocytes play a critical […]